Ernexa Therapeutics Inc.: Form SC 13D/A, filed Mar 31, 2017
Filed with the SEC on Mar 31, 2017 and accepted by EDGAR at Mar 31, 2017, 16:10 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001493152-17-003215. Last ingested by Listed: Nov 6, 2026, 17:52 ET. Listed shows no prices and gives no investment advice.